People who use cannabis almost every day more often have mild hallucinations, unusual thoughts and signs of depression than those who use it occasionally or not at all. The work was published in the Journal of Psychiatric Research.
The subject is psychotic-like experiences - states that resemble the symptoms of psychoses such as schizophrenia but are far milder. These may include mild suspiciousness, rare auditory distortions or unusual beliefs. Such experiences in themselves do not mean a disorder.
Psychiatrist Valerio Ricci of the University of Turin and colleagues noted a gap in the literature: earlier studies examined either healthy volunteers or patients with severe psychoses. The scientists took an intermediate group - people receiving care for anxiety or affective disorders but without psychosis.
The study involved 150 adults aged 18 to 40 from Italian clinics. People with a current or past psychotic disorder were excluded, as were those whose closest relative suffered from one. Participants were divided into three groups. The heavy-use group included 43 people who used cannabis five or more days a week. The occasional-use group included 47 people who did so one to four times a month. The remaining 60 people formed a control group with no experience of use.
Heavy users used an average of 2.8 grams of cannabis a day, while occasional users used about 3.2 grams a month. The former more often smoked, while the latter preferred vaporizers. Self-reports were checked by urine analysis, and data on tobacco, alcohol and medications were also collected.
The main instrument was a scale for assessing the frequency of psychotic experiences. Doctors additionally used standard scales of general functioning. Heavy users reported significantly higher scores on positive symptoms - unusual additions to experience, such as a feeling that others are reading one's thoughts. They also had an elevated level of depressive symptoms. Occasional users scored lower than heavy users but higher than non-users.
Age of onset also played a role. Those who first tried cannabis before age 16.4 had higher symptom scores. The authors recall that the brain has an endocannabinoid system - a network of receptors involved in regulating mood, memory and perception. In adolescence it is actively being restructured, and external cannabinoids could theoretically influence this.
For negative symptoms - lack of motivation and emotional blunting - no significant differences between the groups were found. However, everyday functioning in heavy users was noticeably lower. A link with tobacco also emerged: heavy users who smoked tobacco daily reported higher scores on positive symptoms. Tobacco may accelerate the absorption of tetrahydrocannabinol (THC), the main psychoactive substance in cannabis.
The study is observational: participants were assessed at a single point in time, so a causal relationship cannot be established. It is possible that people with mild hallucinations or depressive thoughts start using cannabis to alleviate their condition. The data are based on self-reports, some were taking other psychiatric medications, and the concentration of substances in the cannabis was not measured. The authors believe that future work would benefit from multi-year follow-up and chemical analysis of the products used.